Heather Boerner

A new CDC model shows the potential power of Undetectable = Untransmittable to curb HIV rates by 2027

Whether for treatment or prevention, women’s interest in injectable antiretrovirals varied based on their relationship with injection.

At one Ryan White clinic in Virginia, the likelihood of multiple health conditions increased over time.

The findings highlight an ongoing need for better integration of HIV care with sexual and reproductive health care.

HIV prevention drugs don’t seem to impact gender-affirming hormone levels, but the opposite might not be true for trans men.

HPV-related anal or genital warts were linked to progression to cancer in a large, long-term study of people with HIV.

Journal retracts study that claimed that people who used condoms for HIV prevention were smarter than those who don’t.

Contradicting a previous study, new data on injectable contraceptives suggest the vaginal microbiome may increase susceptibility to HIV.

Kenya has been using similar technology for three years. DC’s efforts are among the first in the United States.

Nearly eight years after Truvada’s approval for HIV prevention, primary care providers struggle to understand—and prescribe—the pill.

PrEPception, breast feeding and HIV trial participation are front and center in updated federal guidelines.

An excerpt from an upcoming ebook on serodiscordant couples trying to have a baby.